Flu Clinical Trials

Find Flu Clinical Trials Near You

VIRal Pulmonary Infections in Older AGE

Status: Recruiting
Location: See all (20) locations...
Study Type: Observational
SUMMARY

Severe acute respiratory infections (SARIs) represent one of the leading causes of hospitalization and mortality worldwide. These infections are associated with substantial in-hospital mortality and often constitute a turning point in the medium-term prognosis of older patients and those with comorbid conditions. SARIs are most frequently of viral origin, involving well-known pathogens such as Orthomyxoviridae (influenza A and B viruses), Pneumoviridae \[(respiratory syncytial virus (RSV), human metapneumovirus (hMPV)\], Paramyxoviridae \[parainfluenza viruses (PIV)\], adenoviruses, or rhinoviruses, as well as emerging viruses such as pandemic influenza strains and the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of the COVID-19 pandemic. Age-related immune decline (immunosenescence) increases the risk of severe forms and related respiratory or cardiovascular complications. However, the prevalence and burden of the different viral etiologies of Severe acute respiratory infections (SARIs) in older adults remain limited and insufficiently characterized. The primary objective is to determine the proportion of viral respiratory infections attributable to polymerase chain reaction (PCR)-confirmed pathogen agents among hospitalized older subjects (≥60 years old).

Eligibility
Participation Requirements
Sex: All
Minimum Age: 60
Healthy Volunteers: f
View:

• Hospitalized subjects aged ≥ 60 years

• A respiratory sample collected and tested by polymerase chain reaction (PCR) during hospitalisation as part of standard of care

• Note: Reasons for PCR:

⁃ Patients with Severe acute respiratory infection (SARI)

⁃ Patients with symptoms other than SARI

⁃ Systematic PCR testing (in the context of clusters or during the winter season) \* Recent onset of at least one general symptom and at least one functional or physical respiratory sign

∙ General symptoms: fever (which may be absent in older patients), chills, sweating, headache, malaise, myalgia, arthralgia, fatigue, decline in general condition (asthenia, weight loss, anorexia, confusion, or dizziness), digestive disturbances.

‣ Respiratory signs: sore throat, rhinorrhoea (common cold), cough, wheezing, dyspnoea, chest pain, or recent auscultatory abnormalities (diffuse or focal).

‣ Subjects willing to participate, with a non-opposition form completed and signed by the qualified and trained healthcare professional responsible for providing the participant information

‣ Subject affiliated to a health insurance system

Locations
Other Locations
France
CHU Amiens Picardie
NOT_YET_RECRUITING
Amiens
Hôpital Avicenne APHP
RECRUITING
Bobigny
Hôpital Ambroise Paré-APHP
NOT_YET_RECRUITING
Boulogne-billancourt
Hôpital Henri Mondor APHP
NOT_YET_RECRUITING
Créteil
Hôpital Corentin Celton APHP, Gérontologie 1
NOT_YET_RECRUITING
Issy-les-moulineaux
Hôpital Corentin Celton APHP, Gérontologie 2
RECRUITING
Issy-les-moulineaux
Hôpital Charles Foix APHP
NOT_YET_RECRUITING
Ivry-sur-seine
Centre Hospitalier Départemental Vendée_La Roche sur Yon
RECRUITING
La Roche-sur-yon
CH de Versailles
NOT_YET_RECRUITING
Le Chesnay
Hôpital Emile Roux APHP
NOT_YET_RECRUITING
Limeil-brévannes
CHU Nimes
NOT_YET_RECRUITING
Nîmes
HEGP
NOT_YET_RECRUITING
Paris
Hôpital Bichat-APHP
NOT_YET_RECRUITING
Paris
Hôpital Bretonneau APHP
NOT_YET_RECRUITING
Paris
Hôpital Broca - APHP
NOT_YET_RECRUITING
Paris
Hôpital Lariboisière - APHP
NOT_YET_RECRUITING
Paris
Hôpital Sainte Périne
NOT_YET_RECRUITING
Paris
Hôpital St Antoine
NOT_YET_RECRUITING
Paris
CHU Bordeaux
NOT_YET_RECRUITING
Pessac
Hôpital Paul Brousse APHP
NOT_YET_RECRUITING
Villejuif
Contact Information
Primary
Isabelle Dufour
isabelle.dufour@gerondif.org
+33 (0) 185781011
Backup
Prisca Lucas, PhD MPH
prisca.lucas@gerondif.org
+33 (0)185737323
Time Frame
Start Date: 2026-10-22
Estimated Completion Date: 2029-01-21
Participants
Target number of participants: 5900
Sponsors
Leads: Gérond'if

This content was sourced from clinicaltrials.gov